GSK-3 -at the crossroads of cell death and survival

Journal of Cell Science

Volumn 127, Issue 7, 2014, Pages 1369-1378

  Maurer, Ulrich ^a   Preiss, Florian ^a   Brauns Schubert, Prisca ^a   Schlicher, Lisa ^a   Charvet, Céline ^b,c,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b INSTITUT COCHIN   (France)

^c CNRS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Apoptosis; Glycogen synthase kinase 3; GSK 3; Phosphoinositide 3 kinase; PI3K

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53;

APOPTOSIS; CELL DEATH; CELL SURVIVAL; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME REGULATION; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN FUNCTION; METABOLISM; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL DEATH; CELL SURVIVAL; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION;

EID: 84897435029     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.138057     Document Type: Note

References (107)

1. Aberle, H., Bauer, A., Stappert, J., Kispert, A. and Kemler, R. (1997). betacatenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797- 3804.
2. Ambacher, K. K., Pitzul, K. B., Karajgikar, M., Hamilton, A., Ferguson, S. S. and Cregan, S. P. (2012). The JNK- and AKT/GSK3b- signaling pathways converge to regulate Puma induction and neuronal apoptosis induced by trophic factor deprivation. PLoS ONE 7, e46885.
3. Armstrong, J. L., Bonavaud, S. M., Toole, B. J. and Yeaman, S. J. (2001). Regulation of glycogen synthesis by amino acids in cultured human muscle cells. J. Biol. Chem. 276, 952-956.
4. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R. and Cohen, P. (2007). The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315.
5. Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P. and Crabtree, G. R. (1997). Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275, 1930-1933.
6. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. and Baltimore, D. (1995). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376, 167-170.
7. Beurel, E., Michalek, S. M. and Jope, R. S. (2010). Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol. 31, 24-31.
8. Bijur, G. N., Davis, R. E. and Jope, R. S. (1999). Rapid activation of heat shock factor-1 DNA binding by H2O2 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells. Brain Res. Mol. Brain Res. 71, 69-77.
9. Busino, L., Millman, S. E., Scotto, L., Kyratsous, C. A., Basrur, V., O'Connor, O., Hoffmann, A., Elenitoba-Johnson, K. S. and Pagano, M. (2012). Fbxw7aand GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma. Nat. Cell Biol. 14, 375-385.
10. Campbell, C. J., Lee, J. B., Levadoux-Martin, M., Wynder, T., Xenocostas, A., Leber, B. and Bhatia, M. (2010). The human stem cell hierarchy is defined by a functional dependence on Mcl-1 for self-renewal capacity. Blood 116, 1433-1442.
11. Canman, C. E., Gilmer, T. M., Coutts, S. B. and Kastan, M. B. (1995). Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9, 600-611.
12. Charvet, C., Wissler, M., Brauns-Schubert, P., Wang, S. J., Tang, Y., Sigloch, F. C., Mellert, H., Brandenburg, M., Lindner, S. E., Breit, B. et al. (2011). Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. Mol. Cell 42, 584-596.
13. Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J. and Green, D. R. (2010). The BCL-2 family reunion. Mol. Cell 37, 299-310.
14. Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480.
15. Clevers, H. (2013). The intestinal crypt, a prototype stem cell compartment. Cell 154, 274-284.
16. Cole, A., Frame, S. and Cohen, P. (2004). Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event. Biochem. J. 377, 249-255.
17. Collins, M. K., Marvel, J., Malde, P. and Lopez-Rivas, A. (1992). Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J. Exp. Med. 176, 1043-1051.
18. Cross, D. A., Alessi, D. R., Vandenheede, J. R., McDowell, H. E., Hundal, H. S. and Cohen, P. (1994). The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem. J. 303, 21-26.
19. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. and Hemmings, B. A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
20. Cross, D. A., Culbert, A. A., Chalmers, K. A., Facci, L., Skaper, S. D. and Reith, A. D. (2001). Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J. Neurochem. 77, 94-102.
21. Crowder, R. J. and Freeman, R. S. (1998). Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J. Neurosci. 18, 2933-2943.
22. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y. and Greenberg, M. E. (1997). Akt phosphorylation of BAD couples survival signals to the cellintrinsic death machinery. Cell 91, 231-241.
23. del Peso, L., González-García, M., Page, C., Herrera, R. and Nuñez, G. (1997). Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689.
24. Dickens, L. S., Powley, I. R., Hughes, M. A. and MacFarlane, M. (2012). The 'complexities' of life and death: death receptor signalling platforms. Exp. Cell Res. 318, 1269-1277.
25. Ding, Q., He, X., Hsu, J. M., Xia, W., Chen, C. T., Li, L. Y., Lee, D. F., Liu, J. C., Zhong, Q., Wang, X. et al. (2007). Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol. Cell. Biol. 27, 4006-4017.
26. Doble, B. W., Patel, S., Wood, G. A., Kockeritz, L. K. and Woodgett, J. R. (2007). Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/betacatenin signaling shown by using an allelic series of embryonic stem cell lines. Dev. Cell 12, 957-971.
27. Domina, A. M., Vrana, J. A., Gregory, M. A., Hann, S. R. and Craig, R. W. (2004). MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. Oncogene 23, 5301-5315.
28. Dominguez, I., Itoh, K. and Sokol, S. Y. (1995). Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. Proc. Natl. Acad. Sci. USA 92, 8498-8502.
29. Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R. and Greenberg, M. E. (1997). Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661- 665.
30. Dudgeon, C., Peng, R., Wang, P., Sebastiani, A., Yu, J. and Zhang, L. (2012). Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3b and NFkB to suppress tumor cell growth. Oncogene 31, 4848-4858.
31. Dudgeon, C., Peng, R., Wang, P., Sebastiani, A., Yu, J. and Zhang, L. (2012). Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3b and NFkB to suppress tumor cell growth. Oncogene 31, 4848-4858.
32. Embi, N., Rylatt, D. B. and Cohen, P. (1980). Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107, 519-527.
33. Frame, S., Cohen, P. and Biondi, R. M. (2001). A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7, 1321-1327.
34. Franke, T. F., Yang, S. I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R. and Tsichlis, P. N. (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727-736.
35. Franke, T. F., Kaplan, D. R., Cantley, L. C. and Toker, A. (1997). Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275, 665-668.
36. Fukushima, H., Matsumoto, A., Inuzuka, H., Zhai, B., Lau, A. W., Wan, L., Gao, D., Shaik, S., Yuan, M., Gygi, S. P. et al. (2012). SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction. Cell Rep. 1, 434-443.
37. Gyrd-Hansen, M. and Meier, P. (2010). IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat. Rev. Cancer 10, 561-574.
38. Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M. S., Jin, O. and Woodgett, J. R. (2000). Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406, 86-90.
39. Hongisto, V., Smeds, N., Brecht, S., Herdegen, T., Courtney, M. J. and Coffey, E. T. (2003). Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3. Mol. Cell. Biol. 23, 6027-6036.
40. Hongisto, V., Vainio, J. C., Thompson, R., Courtney, M. J. and Coffey, E. T. (2008). The Wnt pool of glycogen synthase kinase 3beta is critical for trophicdeprivation- induced neuronal death. Mol. Cell. Biol. 28, 1515-1527.
41. Hsu, Y. T. and Youle, R. J. (1997). Nonionic detergents induce dimerization among members of the Bcl-2 family. J. Biol. Chem. 272, 13829-13834.
42. Hsu, Y. T., Wolter, K. G. and Youle, R. J. (1997). Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc. Natl. Acad. Sci. USA 94, 3668-3672.
43. Hughes, K., Nikolakaki, E., Plyte, S. E., Totty, N. F. and Woodgett, J. R. (1993). Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12, 803-808.
44. Inuzuka, H., Shaik, S., Onoyama, I., Gao, D., Tseng, A., Maser, R. S., Zhai, B., Wan, L., Gutierrez, A., Lau, A. W. et al. (2011). SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 471, 104- 109.
45. Jope, R. S. and Roh, M. S. (2006). Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr. Drug Targets 7, 1421- 1434.
46. Kaidanovich, O. and Eldar-Finkelman, H. (2002). The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Expert Opin. Ther. Targets 6, 555-561.
47. Kaidanovich-Beilin, O., Beaulieu, J. M., Jope, R. S. and Woodgett, J. R. (2012). Neurological functions of the masterswitch protein kinase-gsk-3. Front. Mol. Neurosci. 5, 48.
48. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J. and Evan, G. (1997). Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385, 544-548.
49. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordán, J., Bellacosa, A., Tsichlis, P. N. and Hay, N. (1997). The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11, 701-713.
50. Kennedy, S. G., Kandel, E. S., Cross, T. K. and Hay, N. (1999). Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol. 19, 5800-5810.
51. Kerr, J. B., Hutt, K. J., Michalak, E. M., Cook, M., Vandenberg, C. J., Liew, S. H., Bouillet, P., Mills, A., Scott, C. L., Findlay, J. K. et al. (2012). DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. Mol. Cell 48, 343-352.
52. Kulikov, R., Boehme, K. A. and Blattner, C. (2005). Glycogen synthase kinase 3- dependent phosphorylation of Mdm2 regulates p53 abundance. Mol. Cell. Biol. 25, 7170-7180.
53. Li, M., Wang, X., Meintzer, M. K., Laessig, T., Birnbaum, M. J. and Heidenreich, K. A. (2000). Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol. Cell. Biol. 20, 9356-9363.
54. Li, Q., Lin, S., Wang, X., Lian, G., Lu, Z., Guo, H., Ruan, K., Wang, Y., Ye, Z., Han, J. et al. (2009). Axin determines cell fate by controlling the p53 activation threshold after DNA damage. Nat. Cell Biol. 11, 1128-1134.
55. Lindner, S. E., Wissler, M., Grunder, A., Aumann, K., Ottina, E., Peintner, L., Brauns-Schubert, P., Preiss, F., Herzog, S., Borner, C. et al. (2013). Increased leukocyte survival and accelerated onset of lymphoma in the absence of MCL-1 S159-phosphorylation. Oncogene [Epub ahead of print] doi:10.1038/onc.2013.469.
56. Linseman, D. A., Butts, B. D., Precht, T. A., Phelps, R. A., Le, S. S., Laessig, T. A., Bouchard, R. J., Florez-McClure, M. L. and Heidenreich, K. A. (2004). Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J. Neurosci. 24, 9993-10002.
57. Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., Zhang, Z., Lin, X. and He, X. (2002). Control of beta-catenin phosphorylation/degradation by a dualkinase mechanism. Cell 108, 837-847.
58. Llambi, F., Moldoveanu, T., Tait, S. W., Bouchier-Hayes, L., Temirov, J., McCormick, L. L., Dillon, C. P. and Green, D. R. (2011). A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol. Cell 44, 517-531.
59. Lu, R., Song, L. and Jope, R. S. (1999). Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells. Neuroreport 10, 1123-1125.
60. MacAulay, K., Doble, B. W., Patel, S., Hansotia, T., Sinclair, E. M., Drucker, D. J., Nagy, A. and Woodgett, J. R. (2007). Glycogen synthase kinase 3alphaspecific regulation of murine hepatic glycogen metabolism. Cell Metab. 6, 329- 337.
61. MacDonald, B. T., Tamai, K. and He, X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9-26.
62. Martin, S. J., Henry, C. M. and Cullen, S. P. (2012). A perspective on mammalian caspases as positive and negative regulators of inflammation. Mol. Cell 46, 387- 397.
63. Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E. and Green, D. R. (2006). Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol. Cell 21, 749-760.
64. Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K. and Tschopp, J. (2001). NF-kappaB signals induce the expression of c-FLIP. Mol. Cell. Biol. 21, 5299- 5305.
65. Morel, C., Carlson, S. M., White, F. M. and Davis, R. J. (2009). Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis. Mol. Cell. Biol. 29, 3845-3852.
66. Ng, S. S., Mahmoudi, T., Danenberg, E., Bejaoui, I., de Lau, W., Korswagen, H. C., Schutte, M. and Clevers, H. (2009). Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade. J. Biol. Chem. 284, 35308-35313.
67. Nikolakaki, E., Coffer, P. J., Hemelsoet, R., Woodgett, J. R. and Defize, L. H. (1993). Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. Oncogene 8, 833-840.
68. Ougolkov, A. V., Bone, N. D., Fernandez-Zapico, M. E., Kay, N. E. and Billadeau, D. D. (2007). Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells. Blood 110, 735-742.
69. Pap, M. and Cooper, G. M. (1998). Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J. Biol. Chem. 273, 19929-19932.
70. Parker, P. J., Caudwell, F. B. and Cohen, P. (1983). Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo. Eur. J. Biochem. 130, 227-234.
71. Qiu, W., Carson-Walter, E. B., Liu, H., Epperly, M., Greenberger, J. S., Zambetti, G. P., Zhang, L. and Yu, J. (2008). PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2, 576-583.
72. Riedl, S. J. and Salvesen, G. S. (2007). The apoptosome: signalling platform of cell death. Nat. Rev. Mol. Cell Biol. 8, 405-413.
73. Ring, D. B., Johnson, K. W., Henriksen, E. J., Nuss, J. M., Goff, D., Kinnick, T. R., Ma, S. T., Reeder, J. W., Samuels, I., Slabiak, T. et al. (2003). Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52, 588-595.
74. Sabbatini, P. and McCormick, F. (1999). Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis. J. Biol. Chem. 274, 24263-24269.
75. Sears, R., Leone, G., DeGregori, J. and Nevins, J. R. (1999). Ras enhances Myc protein stability. Mol. Cell 3, 169-179.
76. Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K. and Nevins, J. R. (2000). Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14, 2501-2514.
77. Somervaille, T. C., Linch, D. C. and Khwaja, A. (2001). Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood 98, 1374-1381.
78. Songyang, Z., Baltimore, D., Cantley, L. C., Kaplan, D. R. and Franke, T. F. (1997). Interleukin 3-dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. USA 94, 11345-11350.
79. Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S. and Mak, T. W. (2001). Regulation of PTEN transcription by p53. Mol. Cell 8, 317-325.
80. Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S.
81. and McMahon, S. B. (2006). Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell 24, 841-851.
82. Taelman, V. F., Dobrowolski, R., Plouhinec, J. L., Fuentealba, L. C., Vorwald, P. P., Gumper, I., Sabatini, D. D. and De Robertis, E. M. (2010). Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143, 1136-1148.
83. Takashima, A. (2006). GSK-3 is essential in the pathogenesis of Alzheimer's disease. J. Alzheimers Dis. 9 Suppl., 309-317.
84. Tang, Y., Luo, J., Zhang, W. and Gu, W. (2006). Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 24, 827-839.
85. ter Haar, E., Coll, J. T., Austen, D. A., Hsiao, H. M., Swenson, L. and Jain, J. (2001). Structure of GSK3beta reveals a primed phosphorylation mechanism. Nat. Struct. Biol. 8, 593-596.
86. Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B. et al. (2008). Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 320, 667-670.
87. Thotala, D. K., Hallahan, D. E. and Yazlovitskaya, E. M. (2008). Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation. Cancer Res. 68, 5859-5868.
88. Thotala, D. K., Geng, L., Dickey, A. K., Hallahan, D. E. and Yazlovitskaya, E. M. (2010). A new class of molecular targeted radioprotectors: GSK-3beta inhibitors. Int. J. Radiat. Oncol. Biol. Phys. 76, 557-565.
89. Trowbridge, J. J., Xenocostas, A., Moon, R. T. and Bhatia, M. (2006). Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nat. Med. 12, 89-98.
90. van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S. et al. (2006). The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10, 389-399.
91. Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M. and Strasser, A. (2003). p53- and druginduced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302, 1036-1038.
92. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. and Baldwin, A. S., Jr (1998). NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680- 1683.
93. Wang, Z., Smith, K. S., Murphy, M., Piloto, O., Somervaille, T. C. and Cleary, M. L. (2008). Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature 455, 1205-1209.
94. Watcharasit, P., Bijur, G. N., Zmijewski, J. W., Song, L., Zmijewska, A., Chen, X., Johnson, G. V. and Jope, R. S. (2002). Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proc. Natl. Acad. Sci. USA 99, 7951-7955.
95. Watcharasit, P., Bijur, G. N., Song, L., Zhu, J., Chen, X. and Jope, R. S. (2003). Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53. J. Biol. Chem. 278, 48872-48879.
96. Welcker, M. and Clurman, B. E. (2008). FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 8, 83-93.
97. Welcker, M., Orian, A., Jin, J., Grim, J. E., Harper, J. W., Eisenman, R. N. and Clurman, B. E. (2004). The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. USA 101, 9085-9090.
98. Welsh, G. I. and Proud, C. G. (1993). Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem. J. 294, 625-629.
99. Welsh, G. I., Miller, C. M., Loughlin, A. J., Price, N. T. and Proud, C. G. (1998). Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett. 421, 125-130.
100. Willis, S. N., Chen, L., Dewson, G., Wei, A., Naik, E., Fletcher, J. I., Adams, J. M. and Huang, D. C. (2005). Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 19, 1294-1305.
101. Yao, R. and Cooper, G. M. (1995). Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006.
102. Ying, Q. L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P. and Smith, A. (2008). The ground state of embryonic stem cell selfrenewal. Nature 453, 519-523.
103. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. and Oren, M. (1991). Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345-347.
104. Yuan, T. L. and Cantley, L. C. (2008). PI3K pathway alterations in cancer: variations on a theme. Oncogene 27, 5497-5510.
105. Zhang, H. H., Lipovsky, A. I., Dibble, C. C., Sahin, M. and Manning, B. D. (2006). S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol. Cell 24, 185-197.
106. Zhao, Y., Altman, B. J., Coloff, J. L., Herman, C. E., Jacobs, S. R., Wieman, H. L., Wofford, J. A., Dimascio, L. N., Ilkayeva, O., Kelekar, A. et al. (2007). Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1. Mol. Cell. Biol. 27, 4328- 4339.
107. Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M. and Hung, M. C. (2004). Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6, 931-940.